In an article titled “VIDEO: Hyperinflammatory ARDS responds to simvastatin”, published June 2, 2017, Dr. Carolyn S. Calfee’s statement on the study results was misquoted. Hypoinflammatory patients treated with simvastatin may have improved outcomes, compared with hyperinflammatory patients treated with placebo.
FROM THE JOURNAL OF THE AMERICAN HEART ASSOCIATION Breastfeeding not only benefits babies; it ...
FROM CANCER Solid organ transplant recipients contribute a disproportionate fraction of pediatric non-Hodgkin lymphoma ...
FROM JOURNAL OF ADOLESCENT HEALTH Better protections of confidential health information of adolescents and ...
